Cytek Biosciences, Inc.

CTKB

Cytek Biosciences, Inc.

CTKB

Insider Sentiment (TTM):

Last Purchase:2025-06-02Last Sale:2024-04-19Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:83,103,506Shares Outstanding:128,704,934Institutional Ownership Pct.:64.57%

Earnings Market Reaction:

Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	74	66	91	93	75	95	99	162	178	169	167	164
Restricted Cash Current	-	-	0	0	0	0	0	0	0	0	0	0
Marketable Securities	188	197	171	168	187	170	179	116	99	101	95	124
Accounts Receivable Net Current	50	52	63	57	56	55	61	53	45	50	56	55
Inventory Net	52	50	48	52	49	45	44	47	50	55	61	67
Prepaid Expense And Other Assets Current	14	15	20	18	15	15	14	13	12	13	13	12
Assets Current	378	379	392	388	383	381	396	390	384	389	392	422
Deferred Tax Assets Deferred Income	-	-	0	38	36	34	33	31	30	33	30	24
Property Plant And Equipment Net	21	20	18	18	18	18	18	19	18	18	18	17
Operating Lease Right Of Use Asset	11	11	11	11	16	10	10	10	9	10	11	12
Goodwill	17	17	17	17	17	17	17	16	16	16	16	16
Intangible Assets Net Excluding Goodwill	15	16	17	18	19	19	20	20	21	22	23	24
Other Assets Noncurrent	6	6	7	4	5	5	5	5	5	4	3	3
Assets	447	449	462	495	493	483	500	491	484	492	494	519
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Trade Current	8	7	6	8	7	6	6	5	3	4	3	5
Settlement Liabilities Current	2	2	2	2	2	2	2	2	3	3	3	3
Accrued Liabilities Current	24	20	23	20	22	19	21	21	15	18	20	21
Other Liabilities Current	21	22	17	16	15	13	13	9	7	8	8	8
Deferred Revenue Current	29	30	29	29	28	28	25	25	24	23	23	23
Liabilities Current	84	81	78	75	73	68	68	63	52	56	56	59
Litigation Reserve Noncurrent	6	7	7	8	8	9	9	17	17	17	16	16
Deferred Revenue Noncurrent	18	18	18	16	17	16	16	15	14	15	15	15
Operating Lease Liability Noncurrent	14	13	14	13	14	7	8	8	8	9	9	10
Debt Instrument Carrying Amount	0	0	1	1	1	1	1	1	1	1	2	2
Other Liabilities Noncurrent	2	2	2	3	2	2	2	2	2	2	2	2
Liabilities	125	121	120	116	116	103	104	106	95	99	101	104
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	452	446	441	435	430	427	431	430	435	429	423	452
Retained Earnings Accumulated Deficit	-133	-121	-102	-58	-52	-47	-35	-45	-46	-35	-29	-35
Accumulated Other Comprehensive Income Loss Net Of…	3	2	2	1	-0	-1	0	0	-0	-2	-1	-2
Stockholders Equity	322	328	342	379	378	380	396	385	389	393	393	416
Liabilities And Stockholders Equity	447	449	462	495	493	483	500	491	484	492	494	519
Common Stock Par Or Stated Value Per Share	0.001	0.001	0	0.001	0.001	0.001	0	0.001	0.001	0.001	0	0.001
Common Stock Shares Authorized	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000
Common Stock Shares Issued	130	129	129	128	127	128	129	130	132	131	131	136
Shares Outstanding	130	129	129	128	127	128	129	130	132	131	131	136

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-14.84%	-8.94%	-9.35%	-	-	-	-	-	-	-	-	-
2025	-26.91%	-6.33%	-2.64%	6.43%	-12.60%	9.51%	40.90%	27.18%	31.42%	1.82%	4.77%	-22.61%
2024	-10.21%	-11.00%	7.34%	2.14%	-4.09%	-16.55%	-9.56%	-11.50%	-20.50%	-6.46%	-18.71%	-40.53%
2023	-	-	-	-13.34%	-38.12%	-51.46%	40.04%	47.53%	44.06%	-2.97%	-7.72%	-16.47%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	4.48	4.69	5.04	5.17	5.22	5.62	5.86	6.21	7.33	6.99	6.97	7.20
Quick Ratio	3.70	3.88	4.16	4.23	4.34	4.74	5.00	5.26	6.15	5.77	5.67	5.85
Working Capital	293.60M	298.37M	314.19M	313.28M	309.56M	312.81M	328.78M	327.39M	331.71M	333.08M	335.83M	363.62M
Leverage & Debt
Debt to Equity	0.39	0.37	0.35	0.31	0.31	0.27	0.26	0.27	0.24	0.25	0.26	0.25
Interest Coverage TTM	-25.34	-23.15	-20.99	-4.46	-3.98	-3.82	-3.10	-21.73	-16.51	-14.36	-13.45	-11.69
Debt Ratio	0.28	0.27	0.26	0.24	0.23	0.21	0.21	0.22	0.20	0.20	0.21	0.20
Efficiency & Turnover
Asset Turnover TTM	0.44	0.44	0.42	0.40	0.40	0.40	0.40	0.40	0.39	0.40	0.38	0.36
Days Sales Outstanding TTM	93.52	95.58	111.49	101.31	93.91	97.56	106.08	97.99	87.01	84.90	99.08	94.72
Receivables Turnover TTM	3.90	3.82	3.27	3.60	3.89	3.74	3.44	3.72	4.19	4.30	3.68	3.85
Per Share Metrics
Diluted EPS TTM	-0.62	-0.57	-0.52	-0.10	-0.05	-0.09	-0.05	-0.08	-0.13	-0.09	-0.09	-0.10
Free Cash Flow Per Share TTM	-0.06	-0.10	-0.07	-0.04	0.09	0.14	0.17	0.22	0.08	0.01	0.00	-0.06
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	53.23%	51.70%	51.84%	53.46%	54.42%	54.94%	55.43%	54.92%	54.97%	55.48%	56.69%	57.75%
Operating Profit Margin TTM	-21.60%	-21.49%	-20.04%	-16.16%	-13.70%	-12.57%	-10.24%	-11.75%	-13.06%	-13.16%	-14.43%	-15.09%
Net Profit Margin TTM	-38.98%	-36.25%	-33.02%	-6.51%	-3.27%	-5.71%	-3.00%	-5.05%	-8.88%	-5.73%	-6.29%	-7.62%
Growth Metrics
Net Revenue Growth (1Y)	5.44%	3.61%	0.52%	-2.18%	-0.85%	-1.86%	3.85%	9.88%	12.60%	20.91%	17.67%	2.38%
Net Income Growth (1Y)	1,158.64%	557.63%	1,005.30%	26.20%	-63.53%	-2.23%	-50.44%	-27.15%	199.44%	455.23%	-571.58%	535.89%
EPS Growth (1Y)	1,134.08%	555.76%	1,030.09%	29.62%	-62.24%	-0.27%	-48.67%	-24.27%	209.64%	474.61%	-568.89%	529.06%
Valuation Metrics
P/E TTM	-7.12	-7.60	-9.70	-34.52	-67.41	-45.73	-140.81	-71.44	-41.78	-76.32	-101.56	-53.90
P/B TTM	1.78	1.72	1.89	1.17	1.14	1.36	2.14	1.88	1.88	2.24	3.14	1.81
P/S TTM	2.77	2.75	3.20	2.25	2.20	2.61	4.23	3.61	3.71	4.38	6.39	4.10
Market Cap	573.51M	562.44M	645.12M	442.59M	431.58M	514.64M	847.67M	725.76M	733.44M	878.48M	1.23B	751.68M
Enterprise Value	499.66M	496.78M	554.26M	349.31M	356.11M	419.34M	748.92M	563.46M	555.52M	709.34M	1.07B	588.05M
Calculated Values
Free Cash Flow TTM	-8.15M	-12.70M	-8.77M	-4.92M	11.84M	17.49M	21.85M	28.76M	10.98M	1.67M	633.00K	-7.72M
Net Debt	-73.85M	-65.67M	-90.85M	-93.28M	-75.47M	-95.30M	-98.75M	-162.30M	-177.92M	-169.14M	-167.63M	-163.63M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-06-02Purchase

Owner: Mccombe, William D.

Title: Chief Financial Officer

Shares: 35,000

Price/Share: $2.78

Value: $97,300.00

Shares Owned: 55,746

Relationship: Officer

Ownership: Direct

2024-04-19Sale

Owner: Yan, Ming

Title: CHIEF TECHNOLOGY OFFICER

Shares: 20,000

Price/Share: $5.87

Value: $117,400.00

Shares Owned: 5,988,502

Relationship: Director,Officer

Ownership: Direct

2024-04-09Sale

Owner: Yan, Ming

Title: CHIEF TECHNOLOGY OFFICER

Shares: 1,900

Price/Share: $7.00

Value: $13,300.00

Shares Owned: 6,008,502

Relationship: Director,Officer

Ownership: Direct

2024-03-19Sale

Owner: Yan, Ming

Title: CHIEF TECHNOLOGY OFFICER

Shares: 20,000

Price/Share: $6.71

Value: $134,200.00

Shares Owned: 6,010,402

Relationship: Director,Officer

Ownership: Direct

2023-12-26Sale

Owner: Jeanmonod, Patrik

Title: Chief Financial Officer

Shares: 3,000

Price/Share: $9.50

Value: $28,500.00

Shares Owned: 93,400

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-06-02	Mccombe, William D.	Officer	Chief Financial Officer	Direct	Purchase	35,000	2.78	$97,300.00	55,746	4
2024-04-19	Yan, Ming	Director,Officer	CHIEF TECHNOLOGY OFFICER	Direct	Sale	20,000	5.87	$117,400.00	5,988,502	4
2024-04-09	Yan, Ming	Director,Officer	CHIEF TECHNOLOGY OFFICER	Direct	Sale	1,900	7.00	$13,300.00	6,008,502	4
2024-03-19	Yan, Ming	Director,Officer	CHIEF TECHNOLOGY OFFICER	Direct	Sale	20,000	6.71	$134,200.00	6,010,402	4
2023-12-26	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,000	9.50	$28,500.00	93,400	4
2023-12-19	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	9.43	$188,600.00	6,042,103	4
2023-11-24	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,000	6.94	$20,820.00	96,400	4
2023-11-20	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	6.03	$120,600.00	7,762,103	4
2023-11-07	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	4.34	$86,800.00	5,275,796	4
2023-10-24	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,000	4.68	$14,040.00	96,084	4
2023-10-19	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	4.80	$96,000.00	7,775,962	4
2023-10-09	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	5.33	$106,600.00	5,295,796	4
2023-09-25	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,000	6.38	$19,140.00	99,084	4
2023-09-19	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	6.49	$129,800.00	7,795,962	4
2023-09-07	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	6.83	$136,600.00	7,605,796	4
2023-08-24	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,000	7.69	$23,070.00	102,084	4
2023-08-21	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	8.07	$161,400.00	7,815,962	4
2023-08-07	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	9.04	$180,800.00	7,613,467	4
2023-07-24	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,000	9.17	$27,510.00	101,768	4
2023-07-19	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	8.76	$175,200.00	7,830,258	4
2023-07-07	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	8.48	$169,600.00	7,633,467	4
2023-06-26	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,000	7.96	$23,880.00	104,768	4
2023-06-20	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	8.18	$163,600.00	7,850,258	4
2023-06-07	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	8.23	$164,600.00	7,653,467	4
2023-05-24	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,000	7.76	$23,280.00	107,768	4
2023-05-19	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	7.19	$143,800.00	7,870,258	4
2023-05-08	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	11.55	$231,000.00	7,664,439	4
2023-04-24	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,000	10.24	$30,720.00	108,201	4
2023-04-19	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	9.71	$194,200.00	7,886,053	4
2023-04-10	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	8.88	$177,600.00	7,684,439	4
2023-03-24	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,000	8.33	$24,990.00	111,201	4
2023-03-20	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	9.29	$185,800.00	7,906,053	4
2023-03-07	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	10.13	$202,600.00	7,704,439	4
2023-02-24	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,000	11.05	$33,150.00	114,201	4
2023-02-21	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	10.94	$218,800.00	7,926,053	4
2023-02-08	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	897	13.53	$12,136.41	7,944,844	4
2023-02-07	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	13.19	$263,800.00	7,720,314	4
2023-02-03	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	1,092	13.50	$14,742.00	7,945,741	4
2023-01-24	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,500	11.05	$38,675.00	76,132	4
2023-01-19	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	11.03	$220,600.00	7,946,833	4
2023-01-09	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	10.66	$213,200.00	7,740,314	4
2022-12-27	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,500	9.77	$34,195.00	79,632	4
2022-12-19	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	10.38	$207,600.00	7,966,833	4
2022-12-07	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	11.86	$237,200.00	7,760,314	4
2022-11-25	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,500	14.30	$50,050.00	83,132	4
2022-11-21	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	14.66	$293,200.00	7,986,833	4
2022-11-14	Ball, Jack	Director	-	Direct	Sale	16,000	14.69	$235,040.00	3,000	4
2022-11-07	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	14.76	$295,200.00	7,785,820	4
2022-10-24	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,500	15.16	$53,060.00	85,563	4
2022-10-19	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	14.42	$288,400.00	8,005,624	4
2022-10-07	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	14.79	$295,800.00	7,805,820	4
2022-09-26	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,500	12.63	$44,205.00	89,063	4
2022-09-19	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	12.42	$248,400.00	8,025,624	4
2022-09-07	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	12.89	$257,800.00	7,825,820	4
2022-08-24	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,500	13.45	$47,075.00	92,563	4
2022-08-19	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	13.62	$272,400.00	8,045,624	4
2022-08-08	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	15.09	$301,800.00	7,841,541	4
2022-08-01	Jeanmonod, Patrik	Officer	Chief Financial Officer	Direct	Sale	3,500	12.80	$44,800.00	94,994	4
2022-07-19	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	11.83	$236,600.00	8,064,415	4
2022-07-07	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	11.19	$223,800.00	7,861,541	4
2022-06-21	Yan, Ming	Director,Officer	Chief Technology Officer	Direct	Sale	20,000	10.06	$201,200.00	8,084,415	4
2022-06-07	Jiang, Wenbin	Director,Officer	President and CEO	Direct	Sale	20,000	10.75	$215,000.00	7,881,541	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

64.57%

Inst. Shares: 83,103,506

Shares Outstanding: 128,704,934

2025-12-31

63.03%

Inst. Shares: 80,518,073

Shares Outstanding: 127,745,939

2025-09-30

61.66%

Inst. Shares: 78,650,061

Shares Outstanding: 127,547,859

2025-06-30

59.49%

Inst. Shares: 75,515,001

Shares Outstanding: 126,934,294

2025-03-31

57.81%

Inst. Shares: 74,199,078

Shares Outstanding: 128,339,481

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	83,103,506	128,704,934	64.57%
2025-12-31	80,518,073	127,745,939	63.03%
2025-09-30	78,650,061	127,547,859	61.66%
2025-06-30	75,515,001	126,934,294	59.49%
2025-03-31	74,199,078	128,339,481	57.81%
2024-12-31	73,927,112	130,611,330	56.60%
2024-09-30	71,717,873	131,003,744	54.74%
2024-06-30	72,307,286	131,440,486	55.01%
2024-03-31	76,998,843	130,920,971	58.81%
2023-12-31	75,273,786	135,283,044	55.64%
2023-09-30	67,375,713	136,173,278	49.48%
2023-06-30	74,795,335	135,918,707	55.03%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Cytek Biosciences, Inc. (CTKB) — SEC Financial Statements & Analysis

Cytek Biosciences, Inc. (CTKB) is a laboratory analytical instruments company, incorporated in DE. Cytek Biosciences, Inc. trades on Nasdaq as: CTKB. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Cytek Biosciences, Inc. reported a 5.44% year-over-year revenue growth, a Gross Profit Margin of 53.23% (TTM), a Debt-to-Equity ratio of 0.39x, a Price-to-Sales (P/S) ratio of 2.77x (TTM), a Price-to-Book (P/B) ratio of 1.78x (TTM), at a market cap of $573.51M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 5.44%
Gross Profit Margin TTM: 53.23%
Debt To Equity: 0.39x
P/S TTM: 2.77x
P/B TTM: 1.78x
Market Cap: $573.51M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Cytek Biosciences, Inc. in?

Cytek Biosciences, Inc. (CTKB) operates in the Laboratory Analytical Instruments industry.

What is CTKB's market cap?

Cytek Biosciences, Inc. (CTKB) has a market capitalization of $573.51M as of 2026-06-30.

What exchange does CTKB trade on?

Cytek Biosciences, Inc. (CTKB) trades on the Nasdaq.

Where is Cytek Biosciences, Inc. incorporated?

Cytek Biosciences, Inc. is incorporated in DE.